|
WO2012103116A1
|
|
Pulmonary administration of rifalazil and analogs thereof
|
|
WO2012103119A1
|
|
Compositions for administering rifalazil and other anti-tuberculosis agents in unit dosage form for oral administration
|
|
BR112013008186A2
|
|
use of ripazil and analogues to treat eye problems
|
|
CA2806362A1
|
|
Administration of rifalazil to immunocompromised patients
|
|
CN102143751A
|
|
Use of rifalazil to treat colonic disorders
|
|
US2009149453A1
|
|
Methods and compositions for treating bacterial infections and diseases associated therewith
|
|
US2009088423A1
|
|
Methods and compositions for treating bacterial infections and diseases associated therewith
|
|
AU2007235379A1
|
|
Pharmaceutical compositions and uses thereof
|
|
AU2006302429A1
|
|
Treatment of peripheral arterial occlusive disease
|
|
BRPI0620157A2
|
|
rifamycin uses
|
|
AU2004275848A1
|
|
Rifalazil formulations
|
|
US7820652B2
|
|
Regimen for the administration of rifamycin-class antibiotics
|
